| Mrs Ann Isenhower Rothschild, LCSW-C | |
|
8615 Ridgelys Choice Dr Ste 212, Nottingham, MD 21236-3028 | |
| (410) 529-2151 | |
| Not Available |
| Full Name | Mrs Ann Isenhower Rothschild |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 8615 Ridgelys Choice Dr Ste 212, Nottingham, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205090495 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 06837 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Ann Isenhower Rothschild, LCSW-C 8615 Ridgelys Choice Dr Ste 212, Nottingham, MD 21236-3028 Ph: (410) 529-2151 | Mrs Ann Isenhower Rothschild, LCSW-C 8615 Ridgelys Choice Dr Ste 212, Nottingham, MD 21236-3028 Ph: (410) 529-2151 |
News Archive
Although some studies have portrayed tight blood sugar control as a potential means of lowering infection rates in critically ill adults, a new study-led by principal investigator Michael Agus, MD, director of the Medicine Critical Care Program at Boston Children's Hospital-found no indication that the approach benefits pediatric patients undergoing heart surgery.
The US Food and Drug Administration (FDA) has approved Pradaxa® (dabigatran etexilate), Boehringer Ingelheim's novel, oral direct thrombin inhibitor for stroke risk reduction in patients with non-valvular atrial fibrillation (AF) marking the first approval of a new oral anticoagulant in the U.S. in more than 50 years.
The Alzheimer's Biomarkers Consortium - Down Syndrome, a multi-institution research team, co-led by members from the University of California, Irvine, has been awarded an unprecedented five-year, $109 million grant by the National Institutes of Health, to expand research on the biomarkers of Alzheimer's disease in adults with Down syndrome.
Basal insulin analogs have revolutionized diabetes care, and especially the treatment of type 2 diabetes, enabling patients to achieve better control of blood glucose levels while reducing hypoglycemic episodes.
Common tests of kidney function and damage predict the risk of death from cardiovascular diseases and all causes, according to a paper from the Chronic Kidney Disease Prognosis Consortium, established last year by Kidney Disease: Improving Global Outcomes.
› Verified 7 days ago
Ms. Margot Allen, LCSW-C Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 4308 Bedrock Cir Apt 101, Nottingham, MD 21236 Phone: 443-834-2306 | |
John A Lafferty, LMSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 8704 Blairwood Rd Apt B2, Nottingham, MD 21236 Phone: 202-683-0049 | |
Ms. Shanine A. Borum, LCSWC Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 24 Bellfalls Way, Nottingham, MD 21236 Phone: 410-782-1888 | |
Rachel Matthews, LCSW-C Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 5022 Campbell Blvd # 4969, Nottingham, MD 21236 Phone: 443-442-1568 | |
Johanne Elaine Etienne Zawitoski, LMSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 9649 Belair Rd Ste 104, Nottingham, MD 21236 Phone: 410-529-1309 Fax: 410-529-1005 | |
Bailey Pararas, LMSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 9649 Belair Rd Ste 104, Nottingham, MD 21236 Phone: 410-529-1309 Fax: 410-529-1005 | |
Nicole Kafka, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 7939 Honeygo Blvd Ste 224, Nottingham, MD 21236 Phone: 410-933-9700 |